Sichenzia Ross Ference Carmel LLP Represents New Era Helium in De-SPAC Transaction and Nasdaq Listing

New York, NY – December 9, 2024 – Sichenzia Ross Ference Carmel LLP announced that it represented New Era Helium, Inc. (“New Era Helium” or the “Company”) in a de-SPAC transaction with Roth CH V Holdings, Inc. and Roth CH Acquisition V. Co. The Company began trading on the Nasdaq Under Symbol “NEHC.”

On December 6, 2024, NEH, Roth CH Acquisition V. Co., and ATW Partners Opportunities Management, LLC (“ATW”) entered into a series of financing transactions including an equity purchase agreement for $75 million, an advance of $10 million in senior secured notes of which $7 million was advanced at closing and up to an additional $3 million will be advanced subject to the satisfaction of certain conditions, and the issuance of warrants to purchase up to an additional $30 million in common stock.

The SRFC team congratulates New Era Helium CEO Will Gray and the rest of the Company on the transaction.

Roth Capital Partners and Craig-Hallum Capital Group acted as financial advisors for the transaction.

The SRFC team was led by partners Ross Carmel, Thiago Spercel and associate Lony Leung.

Sichenzia Ross Ference Carmel LLP represents Madison Global Partners, LLC in an Unsecured Senior Convertible Note and Warrant Offering up to $1 Million

Press Release – New York, NY – December 5, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Madison Global Partners, LLC, in a private placement transaction in which Celularity Inc. (the “Company”) (NASDAQ: “CELU”), in one or more closings, sold unsecured senior convertible notes (the “Notes”) and warrants (the “Purchaser Warrants”) for an aggregate original principal amount of up to $1,000,000, less placement agent discounts and commissions.

The SRFC team was led by partners Gregory Sichenzia and Darrin Ocasio  and associate Jesse Blue.

Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $1.7 Million Registered Direct Offering of SRM Entertainment

New York, NY – December 5, 2024 – Sichenzia Ross Ference Carmel LLP announced that it represented D. Boral Capital LLC as the exclusive placement agent for the $1.7 million registered direct offering of SRM Entertainment, Inc.

The D. Boral Capital team was led by David Boral, Gaurav Verma and Mark Iorio.

The SRFC team was led by partners Ross Carmel, Jeff Wofford and associate Anna Chaykina.

Sichenzia Ross Ference Carmel LLP Represents A.G.P/Alliance Global Partners in $8 Million Private Placement of TransCode Therapeutics

Press Release – New York, NY – December 4, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented A.G.P/Alliance Global Partners as financial advisor in the $8 million private placement offering by TransCode Therapeutics, Inc. (Nasdaq: RNAZ).  

The Sichenzia Ross Ference Carmel LLP team was led by partners Marc Ross and Avital Perlman and associate Rohini Sud.

Sichenzia Ross Ference Carmel LLP Represents RBW Capital Partners in the $3 Million Private Placement Offering of Sadot Group

Sichenzia Ross Ference Carmel LLP Represents Qualigen Therapeutics in $4.5 Million Private Placement Offering

New York, NY – November 20, 2024 – Sichenzia Ross Ference Carmel LLP announced that it represented Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or the “Company) in its $4.5 million private placement offering.

Univest, LLC acted as the exclusive placement agent for the offering. The Univest team was led by Bradley Richmond.

The SRFC team was led by partner Ross Carmel, counsel Jeff Hua and associate Bonnie Bai.

Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in the $12.2 Million Registered Direct Offering of 374Water Inc.

New York, NY – November 18, 2024 – Sichenzia Ross Ference Carmel LLP announced that it represented D. Boral Capital LLC as the exclusive placement agent for the $12.2 million registered direct offering of 374Water Inc.

The D. Boral Capital team was led by David Boral and David Lee.

The SRFC team was led by partners Ross Carmel, Avital Perlman and associate Christian Lichtenberger.

Sichenzia Ross Ference Carmel LLP Represents Joseph Gunnar & Co., LLC in the $1.6 Million Private Placement Offering of Eastside Distilling, Inc.

New York, NY – November 18, 2024 – Sichenzia Ross Ference Carmel LLP announced that it represented Joseph Gunnar & Co., LLC as the exclusive placement agent for the $1.6 million private placement offering of Eastside Distilling, Inc.

The Joseph Gunnar team was led by Peter Serra and Vincent Miscioscia.

The SRFC team was led by partner Ross Carmel, counsel Sharon Carroll and associate Christian Lichtenberger.

Sichenzia Ross Ference Carmel LLP Represents Cyngn Inc. in a $3.5 Million Private Placement

Press Release – New York, NY – November 18, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Cyngn Inc. (NASDAQ: CYN), a developer of industrial autonomous vehicles, in a $3,500,000 private placement of notes and shares of common stock.

The investment is in the form of an Original Issue Discount Senior Note and Shares of Common Stock, resulting in proceeds before expenses to Cyngn of $3.5 million.

Aegis Capital Corp. acted as the exclusive placement agent for the private placement.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia and  Marcelle Balcombe, and senior paralegal Raquel Vazquez.

Sichenzia Ross Ference Carmel LLP Represents Nature’s Miracle Holding Inc. in Closing of $3 Million Public Offering

Press Release – New York, NY – November 14, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Nature’s Miracle Holding Inc. (Nasdaq: NMHI; NMHIW), a leader in vertical farming technology and infrastructure, in approximately $3 million public offering of (a) 25,133,631 units (the “Units”), with each Unit consisting of (i) one share of common stock, par value $0.0001 per share (the “Common Stock”), (ii) one Series A Warrant to purchase one share of Common Stock (the “Series A Warrant”), and (iii) one Series B Warrant to purchase such number of shares of Common Stock as determined on the Reset Date (as defined in the Series B Warrant) (the “Series B Warrant”), at a public offering price of $0.1118 per Unit and (b) 1,700,000 pre-funded units (the “Pre-Funded Units”), with each Pre-Funded Unit consisting of (i) one pre-funded warrant exercisable for one share of Common Stock, (ii) one Series A Warrant, and (iii) one Series B Warrant, at a public offering price of $0.1117 per Pre-Funded Unit, for the aggregate gross proceeds of approximately $3 million, prior to deducting underwriting discounts and other offering expenses.

Boral Capital LLC acted as the sole book running manager for the offering.

The Sichenzia Ross Ference Carmel LLP team was led by partners Huan Lou, David Manno,  and Jeffrey Cahlon, and associate Ronghong Dai.

Sichenzia Ross Ference Carmel LLP Represents Craft Capital Management and D. Boral Capital in the $4 Million Public Offering of Aduro Clean Technologies

New York, NY – November 8, 2024 – Sichenzia Ross Ference Carmel LLP announced that it represented Craft Capital Management LLC and D. Boral Capital LLC in the $4 million public offering of Aduro Clean Technologies Inc.

Craft Capital Management acted as the representative of the underwriters, with D. Boral Capital acting as co-underwriter for the offering.

The SRFC team was led by partners Ross Carmel, Matt Siracusa and associate Lony Leung.

Sichenzia Ross Ference Carmel LLP Represents Safe & Green Holdings Corp. in $2.4 Million Warrant Inducement

New York, NY – November 7, 2024 – Sichenzia Ross Ference Carmel LLP announced that it represented Safe & Green Holdings Corp. (“Safe & Green Holdings” or the “Company”), a leading developer, designer and fabricator of modular structures, in its $2.4 million warrant inducement transaction.

Aegis Capital Corp. acted as the exclusive financial advisor for the transaction. The Aegis team was led by Isaac Eide and Anthony Lapadula.

The SRFC team was led by partners Ross Carmel, Arthur Marcus and associate Jesse Blue.

Sichenzia Ross Ference Carmel LLP represents Thumzup Media Corporation in $7.125 Million Underwritten Public Offering

Press Release – New York, NY – October 31, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Thumzup Media Corporation (OTCQB: TZUP) (NASDAQ: TZUP), a leading provider of innovative social media branding and marketing solutions which allow businesses and brands to pay customers and fans cash through Venmo and PayPal for their posts on social media, in an underwritten public offering of 1,425,000 shares of common stock, at a price of $5.00 per share (the “Shares”). In addition, the Company has granted the underwriters a 45-day over-allotment option to purchase up to an additional 213,750 Shares, less underwriting discounts and commissions.

The SRFC team was led by partner Gregory Sichenzia  and associates Jesse Blue and Chance Moore. 

Sichenzia Ross Ference Carmel LLP Represents Algorhythm Holdings, Inc. in a $2.0 Million Private Placement

Press Release – New York, NY – October 31, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Algorhythm Holdings, Inc. (NASDAQ: RIME), an AI-driven technology and consumer electronics holding company, in a $2,000,000 private placement of notes and shares of common stock.

The investment is in the form of Original Issue Discount Senior Secured Notes and shares of Common Stock, resulting in proceeds before expenses to Algorhythm of $2.0 million.

Univest Securities LLC acted as the exclusive placement agent for the private placement.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia, Marcelle Balcombe, associates Mayank Pradhan, Soumya Cheedi and senior paralegal Raquel Vazquez.

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $4.2 Million Initial Public Offering of Polyrizon Ltd. 

New York, NY – October 30, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Aegis Capital Corp. as sole book running manager in the initial public offering of Polyrizon Ltd. (Nasdaq: PLRZ), a development stage biotech company specializing in the development of innovative medical device hydrogels.  The SRFC team was led by partners Gregory Sichenzia, Jeff Cahlon, Avital Perlman and associates Christian Lichtenberger and Mayank Pradhan.

Sichenzia Ross Ference Carmel LLP represents The Benchmark Company, LLC in $5.2 Million Initial Public Offering of Gelteq Limited 

Press Release – New York, NY – October 30, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented The Benchmark Company, LLC as lead managing underwriter in the $5.2 million initial public offering of Gelteq Limited, a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology.  The SRFC team was led by partners Darrin Ocasio, Avital Perlman, Matthew Siracusa, and  associates Mayank Pradhan and Benasz Hansotia.

Sichenzia Ross Ference Carmel LLP Represents iSpecimen Inc. in the Pricing of $5 Million Public Offering

New York, NY – November 4, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, in the pricing of a $5 million public offering.

The SRFC team was led by partners Ross Carmel, Barry Biggar and associate Benjamin Sklar.

Sichenzia Ross Ference Carmel LLP Represents Dominari Securities in the $1.96 Million Private Placement of Unusual Machines

New York, NY – November 1, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Dominari Securities LLC as the exclusive placement agent for the $1.96 million private placement from Unusual Machines, Inc.

The Dominari Securities team was led by Kyle Wool and Eric Newman.

The SRFC team was led by partners Ross Carmel, Barrett DiPaolo and associate Soumya Cheedi.

Sichenzia Ross Ference Carmel LLP Represents RBW Capital Partners LLC in the $3 Million Public Offering of Digital Brands Group, Inc.

New York, NY – October 30, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented RBW Capital Partners LLC as the exclusive placement agent for the $3 million initial public offering from Digital Brands Group, Inc.

The SRFC team was led by partners Ross Carmel, Jay Yamamoto and associate Chance Moore.

Sichenzia Ross Ference Carmel LLP Represents Spartan Capital Securities in the $11.1 Million Public Offering of 1847 Holdings

New York, NY – October 31, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Spartan Capital Securities, LLC as the sole placement agent for the $11.1 million public offering from 1847 Holdings LLC.

The Spartan Capital Securities team was led by Joe Giamichael, Stephen Faucetta and Brian Duddy.

The SRFC team was led by partners Ross Carmel, Jeff Wofford and attorney Mohit Agrawal.

Sichenzia Ross Ference Carmel LLP represents BullFrog AI Holdings, Inc. in $3.13 Million Registered Direct Offering and Concurrent Private Placement

Press Release – New York, NY – October 24, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, in a $3.13 million registered direct offering and private placement. Gross proceeds to the company will be approximately $3.13 million.  

The SRFC team was led by partner Arthur Marcus and associate Rohini Sud.

Sichenzia Ross Ference Carmel LLP Represents Craft Capital Management and EF Hutton in the $6.08 Million Initial Public Offering of Li Bang International Corporation Inc.

Press Release – New York, NY – October 24, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Craft Capital Management LLC and EF Hutton LLC as underwriters for the $6.08 million initial public offering from Li Bang International Corporation Inc.

Craft Capital Management acted as the representative of the underwriters, with EF Hutton acting as co-underwriter for the offering.

The SRFC team was led by partner Ross Carmel and associate Bonnie Bai.

Sichenzia Ross Ference Carmel LLP Represents US Tiger Securities, Inc. in the $4.8 Million Initial Public Offering of Founder Group Limited

Press Release – New York, NY – October 25, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented US Tiger Securities, Inc. as the sole underwriter for the $4.8 million initial public offering from Founder Group Limited.

The SRFC team was led by partners Ross Carmel, Thiago Spercel and associate Bonnie Bai.

Sichenzia Ross Ference Carmel LLP Represents Spartan Capital Securities in the $2.5 Million Registered Direct Offering of Inspire Veterinary Partners

Press Release – New York, NY – October 23, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Spartan Capital Securities, LLC as the sole placement agent for the $2.5 million registered direct offering from Inspire Veterinary Partners, Inc.

The Spartan Capital Securities team was led by Joe Giamichael.

The SRFC team was led by partners Ross Carmel, Jeffrey Wofford and associate Benjamin Sklar.

Sichenzia Ross Ference Carmel LLP Represents WallachBeth Capital in the $2.66 Million Registered Direct Offering and Concurrent Private Placement of bioAffinity Technologies

Press Release – New York, NY – October 22, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented WallachBeth Capital, LLC as the sole placement agent for the $2.66 million registered direct offering and concurrent private placement from bioAffinity Technologies, Inc.

The SRFC team was led by partners Ross Carmel and Jeffrey Wofford.

Sichenzia Ross Ference Carmel LLP represents Lexaria Bioscience Corp. in $5 Million Registered Direct Offering and Concurrent Private Placement

Press Release – New York, NY – October 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, in a $5 million registered direct offering and private placement priced at-the-market under Nasdaq rules. Gross proceeds to the company will be approximately $5 million.  

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

The SRFC team was led by partners Gregory Sichenzia and Avital Perlman and associates Rohini Sud and Benasz Hansotia. 

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in the $8.2 Million Private Placement of SOBRsafe, Inc. 

New York, NY – October 9, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Aegis Capital Corp. as exclusive placement agent for the $8.2 million private placement from SOBRsafe, Inc.

The SRFC team was led by partners Ross Carmel and Avital Perlman, as well as associate Soumya Cheedi.

Sichenzia Ross Ference Carmel LLP represents A2Z Cust2Mate Solutions Corp. in $4 Million Registered Direct Offering

Press Release – New York, NY – October 2, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ), a global leader in innovative technology solutions, in a registered direct offering of 5,409,999 common shares at a purchase price of $0.75 per share.  Gross proceeds to the company will be approximately $4 million.  

The SRFC team was led by partners Gregory Sichenzia and Avital Perlman and associate Rohini Sud.

Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $5.0 Million Offering  

Press Release – New York, NY – October 1, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, in its best-efforts offering of 5,128,500 common shares and warrants to purchase up to 5,128,500 common shares at a combined offering price of $0.975 per share and associated warrant, priced at-the-market under Nasdaq rules. Total gross proceeds from the offering were approximately $5 million. 

The SRFC team was led by partners Gregory Sichenzia and Avital Perlman and associate Christian Lichtenberger.

Sichenzia Ross Ference Carmel LLP Represents Innovation Beverage Group Limited in Closing of $5.4 Million Initial Public Offering 

Press Release – New York, NY – October 1, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Innovation Beverage Group Limited (Nasdaq: IBG), a developer, manufacturer, marketer, exporter and retailer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands with a focus on premium and super premium brands, in the pricing of its initial public offering of 1,350,000 ordinary shares at a public offering price of $4.00 per share. The shares began trading on The Nasdaq Capital Market on September 26, 2024, under the ticker symbol “IBG”.

The Sichenzia Ross Ference Carmel LLP team was led by partners Darrin Ocasio and Matthew Siracusa, counsel Sharon Carroll, and associate Benjamin Sklar

Sichenzia Ross Ference Carmel LLP Represents Beyond Air, Inc. in a $20.6 Million Private Placement Offering

Press Release – New York, NY – September 27, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Beyond Air, Inc. (NASDAQ: XAIR), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients, in a $20.6 million private placement offering.  Under the terms of the securities purchase agreement, the investors have agreed to purchase shares of the Company’s common stock (or pre-funded warrants in lieu thereof) and accompanying warrants to purchase shares of common stock, at a purchase price of $0.51 per common share (or $0.5099 per pre-funded warrant in lieu thereof) and accompanying warrant in a private placement priced at-the-market under the rules of the Nasdaq Stock Market.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia and Avital Perlman and associate Rohini Sud.

Sichenzia Ross Ference Carmel LLP Represents Bancroft Capital, LLC in $9.5 Million Initial Public Offering of Ordinary Shares of Premium Catering (Holdings) Limited

Press Release – New York, NY –September 27, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Bancroft Capital, LLC  in a $9.5 million initial public offering of ordinary shares of Premium Catering (Holdings) Limited (NASDAQ: PC), a food caterer supplying prepared meals to foreign workers in Singapore as well as operating food stalls and providing buffet catering services. The initial public offering consisted of 1,650,000 ordinary shares issued and sold by Premium Catering (Holdings) Limited and 350,000 ordinary shares by certain selling shareholders at the public offering price of $4.75 per share.

Bancroft Capital, LLC  acted as lead underwriter and representative for the offering.

The Sichenzia Ross Ference Carmel LLP team was led by partners Benjamin Tan and Matthew Siracusa.

Sichenzia Ross Ference Carmel LLP represents INmune Bio Inc. in $13.0 Million Registered Direct Offering

Press Release – New York, NY – September 17, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented INmune Bio (Nasdaq: INMB), a clinical-stage inflammation and immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, in the purchase and sale of 2,341,260 shares of its common stock and warrants to purchase up to an aggregate of 2,341,260 shares of common stock at a combined purchase price per share and accompanying warrant of $5.50 for the institutional investors, and $6.50 per share and accompanying warrant for the Insiders, pursuant to a registered direct offering. The gross proceeds of the offering will be approximately $13.0 million before deducting placement agent fees and other estimated offering expenses

A.G.P./Alliance Global Partners acted as the sole placement agent for the offering.

The SRFC team was led by partners Marc Ross,  Thomas Rose, and David Manno, and associate Jesse Blue.

Sichenzia Ross Ference Carmel LLP Represents Sharps Technology, Inc. in Closing of $3.5 Million Bridge Financing

Press Release – New York, NY – September 24, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sharps Technology, Inc. (NASDAQ: STSS), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, in the closing of its previously announced secured bridge financing of approximately $3.5 million.

Aegis Capital Corp. acted as Exclusive Placement Agent for the private placement.

The Sichenzia Ross Ference Carmel LLP team was led by partner Arthur Marcus and associate Jesse Blue.

Sichenzia Ross Ference Carmel LLP Represents Kaival Brands Innovations Group, Inc. in Definitive Merger and Share Exchange Agreement with Delta Corp Holdings Limited

New York, NY – September 25, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Kaival Brands Innovations Group, Inc. (“Kaival Brands” or the “Company”), the exclusive U.S. distributor of the Bidi® Stick and certain other products manufactured by Bidi Vapor, in a definitive merger and share exchange agreement with Delta Corp Holdings Limited (“Delta”).

Maxim Group LLC served as the exclusive financial advisor to Kaival Brands.

The SRFC team was led by partners Ross Carmel, Jeff Wofford and associate Soumya Cheedi.

Sichenzia Ross Ference Carmel LLP Represents Elevai Labs, Inc. in Pricing of $8.0 Million Public Offering

New York, NY – September 24, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Elevai Labs, Inc. (“Elevai” or the “Company”), a pioneering force in medical aesthetics, in the pricing of an $8.0 million public offering.

Univest Securities, LLC acted as the sole placement agent for the offering.

The SRFC team was led by partners Ross Carmel and Matt Siracusa, as well as associates Lony Leung and Chance Moore.

Sichenzia Ross Ference Carmel LLP Represents Impact Biomedical Inc. in Closing of $4.5 Million Initial Public Offering

Press Release – New York, NY – September 18, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Impact Biomedical Inc. (NYSE: IBO), a company discovering and developing new offerings in human healthcare and wellness, in the pricing of its initial public offering of 1,500,000 shares of its common stock at a public offering price of $3.00 per share. The shares began trading on the NYSE American Market on September 16, 2024, under the ticker symbol “IBO”.

The Sichenzia Ross Ference Carmel LLP team was led by partner Darrin Ocasio and associate Jesse Blue.

Sichenzia Ross Ference Carmel LLP Represents Tenon Medical Inc. in a $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

New York, NY – September 16, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Tenon Medical, Inc. (“Tenon” or the “Company”), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders in a $4.5 million public offering.

The SRFC team was led by partners Ross Carmel, Jeff Wofford and counsel Jeff Hua.

A.G.P./Alliance Global Partners acted as the sole placement agent for the Offering.

Sichenzia Ross Ference Carmel LLP Represents Vuzix Corporation in $20 million Private Placement Offering with Strategic Investor

Press Release – New York, NY – September 16, 2024 – Sichenzia Ross Ference Carmel LLP today announced that it represented Vuzix Corporation (NASDAQ: VUZI), a leading supplier of smart glasses and Augmented Reality (AR) technology and products, in a private placement with a strategic investor. The private placement is for the sale by Vuzix of up to $20 million of common stock and Series B Preferred Stock in three tranches.

The initial closing under the private placement, in which the company sold $10 million of common stock, occurred on September 13, 2024. The second and third closings, each for the sale of $5 million of Series B Preferred Stock, will be tied to certain milestones. The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia, Thomas Rose and Jeff Cahlon and associate Rohini Sud.

Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $8.5 Million Offering

Press Release – New York, NY – September 12, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, in its registered offering of 12,325,000 common shares. Each common share was sold at an offering price of $0.69 per share for gross proceeds of approximately $8.5 million.  

The SRFC team was led by partners Gregory Sichenzia and Avital Perlman, and associates Christian Lichtenberger and Benasz Hansotia.

Sichenzia Ross Ference Carmel LLP Represents NuZee, Inc. in Two PIPE Transactions Totaling $4.3 Million

Press Release – New York, NY – September 11, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented NuZee, Inc. in two recent PIPE transactions, resulting in gross proceeds of approximately $4.3 million. In the first PIPE transaction, the Company sold approximately $3 million of its common stock, which closed on July 18, 2024. In the second PIPE transaction, the Company sold $1.3 million of convertible notes, which closed on September 10, 2024.  

The SRFC team was led by partner Huan Lou and associates Martryn Mak and Bonnie Bai.

Sichenzia Ross Ference Carmel LLP Represents WallachBeth Capital LLC and Revere Securities LLC in the $9 Million Initial Public Offering of Trident Digital Tech Holdings Ltd.

New York, NY – September 12, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented WallachBeth Capital LLC and Revere Securities LLC in an initial public offering of Trident Digital Tech Holdings Ltd., comprised of 1,800,000 American Depositary Shares (“ADSs”).The ADSs are expected to begin trading on the Nasdaq Capital Market on September 10,2024, under the symbol “TDTH.” The closing of the Offering is expected to occur on September 11,2024, subject to the satisfaction of customary closing conditions.

WallachBeth Capital LLC acted as the Lead Underwriter for the Offering and Revere Securities LLC acted as the Co-Manager for the Offering. The WallachBeth team was led by Doug Bantum, Gene McNeill and Ken Bantum. The Revere team was led by Adam Cavise and Jack Chen.

The SRFC team was led by partners Ross Carmel, Barry Biggar and associate Bonnie Bai.

Sichenzia Ross Ference Carmel LLP Represents EF Hutton in the $4 Million Private Placement of Solidion Technology, Inc.

New York, NY – September 11, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented EF Hutton as exclusive placement agent for the $4 million private placement from Solidion Technology, Inc.

The EF Hutton team was led by David Boral, Gaurav Verma and Mark Iorio.

The SRFC team was led by partner Ross Carmel.

Sichenzia Ross Ference Carmel LLP Represents Joseph Gunnar & Co., LLC in $0.4 Million Registered Direct Offering of Eastside Distilling

Press Release – New York, NY – September 6, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Joseph Gunnar & Co.as exclusive placement agent for the $0.4 million registered direct offering from Eastside Distilling.

The Joseph Gunnar & Co. team was led by Chairman & Chief Executive Officer Joseph Alagna, Managing Director Peter Serra and Vice President Vincent Miscioscia.

The SRFC team was led by partners Ross Carmel and Matt Siracusa and associate Christian Lichtenberger.

Sichenzia Ross Ference Carmel LLP Represents Qualigen Therapeutics, Inc. in $3.47 Million Public Offering

Sichenzia Ross Ference Carmel LLP Represents 60 Degrees Pharmaceuticals, Inc. in $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Press Release – New York, NY – September 4, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented 60 Degrees Pharmaceuticals, Inc. (“60P”) in its $4 million private placement priced at-the-market (ATM) under Nasdaq rules.

H.C. Wainwright acted as the exclusive placement agent for the private placement.

The SRFC team was led by partners Ross Carmel, counsel Jeff Hua and associate Tong Wu.

Sichenzia Ross Ference Carmel LLP represents Virax Biolabs Group Limited in a $5 Million Registered Direct Offering

Press Release – New York, NY – August 23, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Virax Biolabs Group Limited (NASDAQ: VRAX) (“Virax”), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, in a $5 million registered direct offering to certain institutional investors.

Virax issued an aggregate of 1,108,892 of its ordinary shares at a purchase price of $4.50 per share.

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

The SRFC team was led by partners Greg Sichenzia, Barrett DiPaolo and Matt Siracusa and associate Benasz Hansotia

Sichenzia Ross Ference Carmel LLP Represents Wilson-Davis & Co., Inc. in $11.25 Million Initial Public Offering of Ordinary Shares of JBDI Holdings Limited

Press Release – New York, NY – August 29, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Wilson-Davis & Co., Inc. in a $11.25 million initial public offering of ordinary shares of JBDI Holdings Limited (NASDAQ: JBDI), a leading provider of environmentally friendly and efficient reconditioning and recycling services for drums and containers in Singapore and Southeast Asia. The initial public offering consisted of 1,750,000 ordinary shares issued and sold by JBDI Holdings Limited and 500,000 ordinary shares by certain selling shareholders at the public
offering price of $5.00 per share.

Wilson-Davis & Co., Inc. acted as lead underwriter and representative for the offering.

The Sichenzia Ross Ference Carmel LLP team was led by partners Benjamin Tan and Matthew Siracusa.

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $20 Million PIPE and Warrant Exercise of Uber and NVIDIA-backed Serve Robotics Inc.

New York, NY – August 28, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Aegis Capital Corp. as exclusive placement agent in connection with a securities purchase agreement resulting in gross proceeds of $20 million to Serve Robotics Inc. (Nasdaq: SERV).  Backed by Uber and NVIDIA, Serve Robotics develops advanced, AI-powered, low-emissions sidewalk delivery robots that endeavor to make delivery sustainable and economical.  Serve Robotics was spun off from Uber in 2021.  The transaction closed on August 28, 2024.

Serve Robotics completed a private placement to a single institutional investor of pre-funded warrants to purchase up to 555,555 shares of the company’s common stock, together with a warrant to purchase up to 555,555 shares of common stock at an exercise price of $10.00 per share. Each unit of pre-funded warrant and common warrant was sold at a purchase price of $9.00. The common warrants are exercisable upon issuance and will expire five and a half years from the date of issuance.

In addition, Serve Robotics agreed with a single institutional investor to exercise for cash certain outstanding warrants to purchase an aggregate of 2,500,000 shares of Common Stock at their original exercise price of $6.00 per share, for gross proceeds of $15 million. In consideration for such exercise, the investor received, in a private placement, new warrants to purchase up to 2,200,000 shares of common stock with an exercise price of $10.00 per share. These new warrants are exercisable upon issuance and will expire five and a half years from the date of issuance.

Aegis Capital Corp. acted as the exclusive placement agent for the transaction.

The Firm previously represented Aegis Capital as exclusive placement agent in a $15 million private placement offering by Serve Robotics of common stock warrants and pre-funded common stock warrants in July 2024; as the sole book-running manager in Serve Robotics’ $40 million underwritten public offering of common stock and uplisting to Nasdaq in April 2024; and as co-placement agent in Serve Robotics’ $15.7 million “APO” reverse merger and private placement in July – October 2023.  The Firm also represented Laidlaw & Company (UK) Ltd. as co-placement agent in a $3 million convertible note bridge financing for Serve Robotics in April 2023.

The SRFC team was led by partners Gregory Sichenzia, Barrett DiPaolo and Matthew Siracusa and associate Benjamin Sklar.

Sichenzia Ross Ference Carmel LLP Represents Cathay Securities, Inc. in the $8.5 million IPO of Reitar Logtech Holdings Limited

New York, NY – August 27, 2024 – Sichenzia Ross Ference Carmel LLP today announced that it represented Cathay Securities, Inc. in the $8.5 million IPO of Reitar Logtech Holdings Limited (Nasdaq: RITR) (the “Company”), a comprehensive logistics solutions provider in Hong Kong.

Cathay Securities, Inc. is acting as sole book runner and lead underwriter for the Offering. The Cathay Securities team was led by Shell Li.

The SRFC team was led by partners Ross Carmel, Barry Biggar and associate Bonnie Bai.

Sichenzia Ross Ference Carmel LLP Represents Dominari Securities in a $4.4 Million Private Placement of Jones Soda Co.

New York, NY – August 23, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Dominari Securities LLC (“Dominari”), in a $4.4 million private placement of Jones Soda Co, a leading developer of sodas and cannabis-infused beverages.

The Dominiari Securities LLC team was led by Kyle Wool and Dr. Cosme Ordonez.

The SRFC team was led by partner Ross Carmel and associate Mohit Agrawal.

Sichenzia Ross Ference Carmel LLP represents EF Hutton LLC in a $2.9 Million Public Offering of New Horizon Aircraft

Press Release – New York, NY – August 21, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented EF Hutton LLC in a $2.9 million public offering of New Horizon Aircraft Ltd. (NASDAQ: HOVR), an advanced aerospace engineering company that is developing one of the world’s first hybrid eVTOL.

The SRFC team was led by partners Darrin Ocasio, Avital Perlman, Matthew Siracusa, and associate Jesse Blue.

Sichenzia Ross Ference Carmel LLP Represents EF Hutton LLC in a $16 Million Debt Financing Transaction

New York, NY – August 19, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented EF Hutton LLC in a $16 million debt financing transaction between NRx Pharmaceuticals, Inc. (“NRx Pharmaceuticals” or the “Company”), a clinical-stage biopharmaceutical company and Anson Funds.

EF Hutton LLC acted as the exclusive placement agent for the Financing.

The SRFC team was led by partner Ross Carmel.

Sichenzia Ross Ference Carmel LLP Represents Siyata Mobile Inc. in a $4 Million Public Offering

New York, NY – August 19, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Siyata Mobile Inc. (“Siyata” or the “Company”), a global developer and vendor of Push-to-Talk over Cellular (PoC) handsets and accessories, in a $4 million public offering.

Spartan Capital Securities, LLC acted as the sole placement agent in connection with the offering.

The SRFC team was led by partners Ross Carmel, Thiago Spercel, and associate Mohit Agrawal.

Sichenzia Ross Ference Carmel LLP represents Greenlane Holdings, Inc. in a $6.5 Million Private Placement

Press Release – New York, NY – August 14, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Greenlane Holdings, Inc. (NASDAQ:GNLN) (“Greenlane” or the “Company”), a premier global platform for the development and distribution of premium cannabis accessories, packaging, vape solutions, and lifestyle products, in the closing of a $6.5 million private placement before deducting fees to the placement agent and other offering expenses payable by the company. 

The Company issued an aggregate of 2,363,637 units and pre-funded units. The pre-funded units will be sold at the same purchase price as the units, less the pre-funded warrant exercise price of $0.001. Each unit and pre-funded unit consisted of one share of common stock (or one pre-funded warrant) and two common warrants, each exercisable for one share of common stock at an exercise price of $2.50 per share. The common warrant will be exercisable on the initial exercise date described in the common warrant and will expire 5 years from such date.

Aegis Capital Corp. acted as the Exclusive Placement Agent for the private placement.

The SRFC team was led by partner Arthur Marcus, associate Jesse Blue, and Paralegal Kennedy McCann

Sichenzia Ross Ference Carmel LLP Represents WallachBeth Capital, LLC in $8.6 Million Initial Public Offering of QMMM Holdings Limited

New York, NY – August 12, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented WallachBeth Capital LLC (the “Underwriter”) in the initial public offering and partial exercise of the Underwriters’ over-allotment option of the ordinary shares of QMMM Holdings Limited (“QMMM”). The ordinary shares commenced trading on The Nasdaq Capital Market on July 19, 2024. The initial public offering consisted of 2,150,000 ordinary shares of QMMM at a price of $4.00 per share and closed on July 22, 2024. The partial exercise of the Underwriters’ over-allotment option closed on August 8, 2024. 

QMMM is a digital media advertising, virtual avatar & virtual apparel technology service provider in Hong Kong. 

The SRFC team was led by partners Huan Lou, David Manno and associate Christian Lichtenberger.  

Sichenzia Ross Ference Carmel LLP Represents MKDWELL Tech Inc. in Business Combination with Cetus Capital Acquisition Corp.

Press Release – New York, NY – August 6, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented MKDWELL Tech Inc. (NASDAQ: MKDW) (“MKD” or the “Company”) as U.S. counsel in the successful completion of its previously announced business combination with Cetus Capital Acquisition Corp.

The ordinary shares of the Company began trading on the Nasdaq Global Market on August 1, 2024, under the ticker symbol “MKDW” and the Company’s warrants began trading on the Nasdaq Capital Market on the same date under the ticker symbol “MKDWW”. MKD is an automotive electronics manufacturer and operates primarily through its key subsidiaries: MKD Jiaxing and MKD Shanghai in Mainland China, and MKD Taiwan in Hsinchu, Taiwan. 

Partner David Manno commented, “We congratulate MKD on the completion of their business combination and Nasdaq listing.” 

The Sichenzia Ross Ference Carmel LLP team was led by partners Huan Lou and David Manno and associates Martryn Mak and Ronghong Dai.

Sichenzia Ross Ference Carmel LLP Represents WallachBeth Capital in a $1.75 Million Registered Direct, Concurrent Private Placement and Warrant Inducement of bioAffinity Technologies, Inc. 

New York, NY – August 6, 2024 – Sichenzia Ross Ference Carmel LLP announced it has represented WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, in a registered direct, concurrent private placement and warrant inducement of bioAffinity Technologies, Inc. priced at $1.75 million.

The SRFC team was led by partners Ross Carmel, Jeff Wofford and associate Soumya Cheedi.

Sichenzia Ross Ference Carmel LLP Represents Brookline Capital Markets in the $6.4 Million Initial Public Offering of OS Therapies Incorporated

New York, NY – August 2, 2024 – Sichenzia Ross Ference Carmel LLP (SRFC) represented Brookline Capital Markets, a division of Arcadia Securities LLC, in the $6.4 million initial public offering of OS Therapies Incorporated (NYSE: OSTX), a clinical stage oncology company focused on the treatment of osteosarcoma and other solid tumors in children and young adults.

Brookline Capital Markets acted as the sole book-running manager for the offering.

The SRFC team was led by partners Marc Ross and Tom Rose, and associate Benjamin Sklar.

Sichenzia Ross Ference Carmel LLP Represents Nature’s Miracle Holding Inc. in $1.2 Million Public Offering

Press Release – New York, NY – August 2, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Nature’s Miracle Holding Inc. (NASDAQ: NMHI; NMHIW), a growing agriculture technology company providing equipment and services to growers in the Controlled Environment Agriculture industry, in approximately $1.2 million public offering of 5,000,000 units at a public offering price of $0.24 per unit, with each unit consisting of one share of common stock and one Series A warrant to purchase one share of common stock.  EF Hutton LLC acted as the sole book running manager for the offering.

The Sichenzia Ross Ference Carmel LLP team was led by partners Huan Lou and David Manno, counsel Jeffrey Hua and associate Ronghong Dai.

Sichenzia Ross Ference Carmel LLP Represents A.G.P./Alliance Global Partners  in the $69 Million Initial Public Offering of DT Cloud Star Acquisition Corporation  

Press Release – New York, NY – August 2, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented A.G.P. / Alliance Global Partners in the $69 million initial public offering, including full exercise of Underwriter’s Over-Allotment Option, of DT Cloud Star Acquisition Corporation, a blank check company. The offering consisted of 6,900,000 units at a price of $10.00 per unit.  This includes the exercise in full by the underwriters’ over-allotment option to purchase up to an additional 900,000 units. Each unit consists of one ordinary share and one right to receive one-ninth (1/9) of one ordinary share upon the consummation of an initial business combination. The IPO closed on July 26, 2024.  The units are listed on The Nasdaq Global Market (“Nasdaq”) and began trading under the ticker symbol “DTSQU” on July 25, 2024. Once the securities comprising the units begin separate trading, the ordinary shares and the rights are expected to be traded on Nasdaq under the symbols “DTSQ” and “DTSQR,” respectively.  

The Sichenzia Ross Ference Carmel LLP team was led by partners Huan Lou, David Manno, and associates Martryn Mak and Ronghong Dai.

Sichenzia Ross Ference Carmel LLP Represents ThinkEquity in a $5 Million Public Offering

New York, NY – July 31, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented ThinkEquity in a $5 million public offering of Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or (“Better Choice”), a pet health and wellness company.

ThinkEquity is acting as the sole book-runner for the offering. Its team was led by Joe (Ramnarain) Jaigobond, Eric Lord and Christopher Penny.

The SRFC team was led by partners Ross Carmel, Jay Yamamato, Jeff Cahlon, law clerk Rohini Sud and associate Benasz Hansotia.

Sichenzia Ross Ference Carmel LLP Represents ThinkEquity in a $10.8 Registered Direct Offering

New York, NY – July 30, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented ThinkEquity in a $10.8 registered direct offering of CEL-SCI Corporation (“CEL-SCI” or the “Company”), a cancer immunotherapy company.

ThinkEquity is acting as sole placement agent for the offering. Its team was led by Joe (Ramnarain) Jaigobond, Eric Lord, and Brian Carstens.

The SRFC team was led by partners Ross Carmel, Avital Perlman and associate Soumya Cheedi.

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $15 Million PIPE of Uber and NVIDIA-backed Serve Robotics Inc.

New York, NY – July 24, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Aegis Capital Corp. as exclusive placement agent in a $15 million private placement offering by Serve Robotics Inc. (Nasdaq: SERV) of common stock warrants and pre-funded common stock warrants. Backed by Uber and NVIDIA, Serve Robotics develops advanced, AI-powered, low-emissions sidewalk delivery robots that endeavor to make delivery sustainable and economical.  Serve Robotics was spun off from Uber in 2021.  The Firm previously represented Aegis Capital as the sole book-running manager in Serve Robotics’ $40 million underwritten public offering of common stock and uplisting to Nasdaq in April 2024, and as co-placement agent in Serve Robotics’ $15.7 million “APO” reverse merger and private placement in July – October 2023.  The Firm also represented Laidlaw & Company (UK) Ltd. as co-placement agent in a $3 million convertible note bridge financing for Serve Robotics in April 2023.

The SRFC team was led by partners Gregory Sichenzia, Barrett DiPaolo and Matthew Siracusa and associate Benjamin Sklar.

Sichenzia Ross Ference Carmel LLP Represents VCI Global Limited (Nasdaq: VCIG) in a $3 Million Registered Direct Offering.

New York, NY – July 24, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it has represented VCI Global Limited (Nasdaq: VCIG) in a $3 million registered direct offering.

The SRFC team was led by partners Ross Carmel and Jeff Wofford, and associate Tong Wu. 

Sichenzia Ross Ference Carmel LLP Represents EF Hutton LLC in a $2 Million Underwritten Public Offering 

New York, NY – July 12, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented EF Hutton LLC in a $2 Million Underwritten Public Offering of Shineco, Inc., a provider of innovative diagnostic medical products and related medical devices. 

EF Hutton LLC is acting as the sole book-running manager for the offering. Its team was led by David Boral, Stephanie Hu, Ryan Zhang and Mark Iorio.

The SRFC team was led by partners Ross Carmel, Matt Siracusa and Rohini Sud. 

Sichenzia Ross Ference Carmel LLP Represents Spartan Capital Securities LLC in a $6 Million Public Offering of Inspire Veterinary Partners, Inc.

New York, NY – July 8, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Spartan Capital Securities LLC in a $6 million public offering of Inspire Veterinary Partners, Inc., an owner and provider of pet health care services throughout the U.S.

Spartan Capital Securities LLC was the sole placement agent in connection with the offering. Its team was led by Joe Giamichael and Harry Warnick.

The SRFC team was led by partners Ross Carmel, Jeff Wofford and associate Soumya Cheedi.

Sichenzia Ross Ference Carmel LLP Represents EF Hutton in a $2.25 Million Registered Direct Offering of Datasea Inc.

Press Release – New York, NY – July 2, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented EF Hutton in a $2.25 million registered direct offering of Datasea Inc., a Nevada corporation engaged in innovative businesses in high-tech intelligent acoustics and 5G-Artificial Intelligence (“AI”) multimodal communication technology in the United States and China.

EF Hutton LLC was the exclusive placement agent for the offering. Its team was led by David Boral, Stephanie Hu, Mark Iorio and Ryan Zhang.

The SRFC team was led by partners Ross Carmel, Avital Perlman and associate Bonnie Bai.

Sichenzia Ross Ference Carmel LLP Represents Ayurcann Holdings Corp. in a Business Combination with Arogo Capital Acquisition Corp.

New York, NY – June 27, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it has represented Ayurcann Holdings Corp. (“Ayurcann” or the “Company”), an award winning Canadian cannabis extraction company specializing in the processing and manufacturing of pharma grade cannabis and hemp for various derivative cannabis products, in a business combination with Arogo Capital Acquisition Corporation (“Arogo”), a special purpose acquisition company.

The SRFC team was led by partners Ross Carmel, Glenn Burlingame and counsel Sharon Carroll.

Sichenzia Ross Ference Carmel LLP Represents Madison Global Partners, LLC, in a $11 Million Registered Direct Offering of authID, Inc.

Sichenzia Ross Ference Carmel LLP Represents Infintium Fuel Cell Systems, Inc. in a Business Combination with Goldenstone Acquisition Limited

Sichenzia Ross Ference Carmel LLP Represents Kaival Brands in a $6 Million Public Offering 

New York, NY – June 24, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Kaival Brands Innovations Group, Inc., (NASDAQ: KAVL) (“Kaival Brands”, the “Company”), the exclusive U.S. distributor of all products manufactured by Bidi Vapor, LLC (“Bidi Vapor”) in a $6.0 million public offering. The team announced the pricing of a public offering of 3,921,500 units at a public offering price of $1.53 per unit (the “Offering”).

Maxim Group LLC is the placement agent.

The SRFC team was led by partners Ross Carmel, Jeff Wofford and associate Soumya Cheedi.

Sichenzia Ross Ference Carmel LLP represents Presidio Property Trust, Inc. in Pricing of $1.74 Million Public Offering of Series D Preferred Stock

Press Release – New York, NY – June 21, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Presidio Property Trust, Inc., an internally managed, diversified real estate investment trust, in the pricing of its public offering of 109,054 shares of its 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock par value $0.01 per share (the “Series D Preferred Stock”) at a price to the public of $16.00 per share. 

The SRFC team was led by partners Darrin M. Ocasio and Avital Perlman, associate Rohini Sud, and law clerk Nishkarsh Jakhar.  

Sichenzia Ross Ference Carmel LLP Represents Sharps Technology, Inc. in $3.4 Million Reg A+ Warrant Inducement Offering

Press Release – New York, NY – June 17, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sharps Technology, Inc. (NASDAQ: STSS), an innovative medical device and pharmaceutical company offering patented, best-in-class syringe products, in a $3.39 million Reg A+ warrant inducement offering. The offering combined a Reg A offering on Form 1-A and the exercise of existing warrants. 

The Sichenzia Ross Ference Carmel LLP team was led by partner Arthur Marcus and associate Jesse Blue.

Sichenzia Ross Ference Carmel Represents Joseph Gunnar & Co., LLC in a $3 Million Private Placement for Beeline Financial Holdings Inc.

Sichenzia Ross Ference Carmel LLP Represents BioSig Technologies, Inc. in $3 Million Registered Direct Offering

Press Release – New York, NY – May 30, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, in a $3 million registered direct offering. The Company sold an aggregate of 1,507,683 shares of common stock in a registered direct offering at a purchase price of $1.91 per share, along with a concurrent private placement of warrants to purchase 1,570,683 shares of common stock at an exercise price of $1.78 per share. H.C. Wainwright & Co acted as the sole placement agent for the offering.  

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia, Barrett S. DiPaolo, and Avital Perlman, and associates Christian Lichtenberger and Mayank Pradhan

Sichenzia Ross Ference Carmel LLP Represents BriaCell Therapeutics Corp. in $5 Million Registered Direct Offering

Press Release – New York, NY – May 17, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, in a $5 million registered direct offering.  The Company sold an aggregate of 2,402,935 common shares (or pre-funded warrants in lieu thereof) and warrants to purchase 2,402,935 common shares.  A.G.P./Alliance Global Partners acted as the sole placement agent for the offering.  

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia, Avital Perlman, Glenn Burlingame, law clerk Soumya Cheedi, and senior paralegal Raquel Vazquez.

Sichenzia Ross Ference Carmel LLP Represents Siyata Mobile in a $4 Million Public Offering

New York, NY – May 8, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it has represented Siyata Mobile Inc. (Nasdaq: SYTA) (Nasdaq: SYTAW) (“Siyata” or the “Company”), a global developer and vendor of Push-to-Talk over Cellular (PoC) handsets and accessories, in a public offering of $4.0 million of common shares, and/or pre-funded warrants to purchase common shares at a public offering price of $1.30 per share.

​​Spartan Capital Securities, LLC acted as the sole placement agent in connection with the offering.

The SRFC team was led by partners Ross Carmel, Thiago Spercel and associate Mohit Agrawal.

Sichenzia Ross Ference Carmel LLP Represents INmune Bio Inc. in $9.7 Million Registered Direct Offering

Press Release – New York, NY – April 29, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, in approximately $9.7 million registered direct offering of 986,000 shares of its common stock and warrants to purchase up to an aggregate of 986,000 shares of its common stock. Maxim Group LLC acted as the sole placement agent for the offering

The Sichenzia Ross Ference Carmel LLP team was led by partners Marc J. Ross, Thomas Rose, David Manno, Matt Siracusa and law clerk Soumya Cheedi.

Sichenzia Ross Ference Carmel LLP Represents INmune Bio Inc. in $4.8 Million Registered Direct Offering

Press Release – New York, NY – April 24, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, in approximately $4.8 million registered direct offering of its common sale and purchase of 571,592 shares of its common stock  and warrants to  purchase 571,592 shares of its common stock.

The Sichenzia Ross Ference Carmel LLP team was led by partners Marc J. Ross, Thomas Rose, David Manno, Matt Siracusa and associate Soumya Cheedi.

Sichenzia Ross Ference Carmel LLP Represents Alternus Clean Energy, Inc. in a $2.16 Million Private Placement

New York, NY – April 24, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Alternus Clean Energy, Inc. (NASDAQ: ALCE) (“Alternus” or the “Company”), a transatlantic clean energy independent power producer, in the closing of a $2.16 million private placement of convertible notes and warrants. 

The investment is in the form of a Senior Unsecured Original Issue 8% Discount Convertible Note, resulting in proceeds before expenses to Alternus of $2.0 million.

Maxim Group LLC acted as the exclusive placement agent for the private placement.

The SRFC team was led by partners Ross Carmel, Jeff Wofford and associate Mohit Agrawal.

Sichenzia Ross Ference Carmel LLP Represents Genetic Technologies Limited in a $2 Million Registered Direct Offering and Concurrent Private Placement

New York, NY – April 22, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”) in a $2 million registered direct offering and private placement.

The Company issued an aggregate of 1,000,000 American Depositary Shares (“ADSs”) (or ADS equivalents in lieu thereof), each representing 30 ordinary shares of the Company, at an offering price of $2.00 per ADS. In addition, the Company has issued unregistered warrants to purchase up to 1,000,000 ADSs. The warrants have an exercise price of $2.00 per ADS, are exercisable upon issuance and will expire five years following issuance.

The Sichenzia Ross Ference Carmel LLP team was led by partners Darrin M. Ocasio and Avital Perlman and associate Mayank Pradhan.

Sichenzia Ross Ference Carmel LLP Represents Craft Capital Management LLC and R.F. Lafferty & Co. in a $4.2 Million Initial Public Offering and Nasdaq Listing of Mingteng International Corporation

New York, NY – April 22, 2024 – Sichenzia Ross Ference Carmel LLP (SRFC) today announced that it represented Craft Capital Management LLC and R.F. Lafferty & Co. in an initial public offering of Mingteng International Corporation Inc. (the “Company” or “Mingteng International”), an automotive mold developer and supplier in China. The pricing of its initial public offering includes 1,275,000 ordinary shares, 1,050,000 of which are being offered by the Company and 225,000 by a selling shareholder, at a public offering price of US$4.00 per ordinary share. The ordinary shares have been approved for listing on the Nasdaq Capital Market. 

The SRFC team was led by partners Ross Carmel, Phil Magri and associate Tong Wu. 

Sichenzia Ross Ference Carmel LLP Represents EF Hutton LLC in a $2 Million Common Stock Offering of NRx Pharmaceuticals, Inc.

New York, NY – April 22, 2024 – Sichenzia Ross Ference Carmel LLP (SRFC) announced that it represented EF Hutton LLC as the sole book-runner in a public offering of NRx Pharmaceuticals, Inc. (“NRx Pharmaceuticals” or the “Company”), a clinical-stage biopharmaceutical company. The pricing of its underwritten public offering of shares of its common stock are at a public offering price of $3.30 per share, for aggregate gross proceeds of approximately $2.0 million, prior to deducting underwriting discounts and other offering expenses.

The SRFC team was led by partners Ross Carmel, Avital Perlman and associate Christian Lichtenberger.

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $40 Million Common Stock Offering and Nasdaq Uplisting of Serve Robotics Inc.

New York, NY – April 22, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Aegis Capital Corp, as the sole book-running manager in a common stock offering and uplisting to Nasdaq of Serve Robotics Inc., a leading autonomous sidewalk delivery company. The offering consisted of 10,000,000 shares of common stock at a price to the public of $4.00 per share, for aggregate gross proceeds of $40 million, prior to deducting underwriting discounts and offering expenses. The offering includes the participation of one of Serve’s largest stockholders and strategic partners, Postmates, LLC, a wholly-owned subsidiary of Uber Technologies Inc (NYSE: UBER).

The SRFC team was led by partners Gregory Sichenzia, Barret DiPaolo, Matthew Siracusa and associate Benjamin Sklar.

Sichenzia Ross Ference Carmel LLP Represents Safety Shot, Inc. in a $5 Million Private Placement

Press Release – New York, NY – April 16, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Safety Shot, Inc. (Nasdaq: SHOT), the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity, in a $5,000,000 private placement from the issuance of 2,369,668 shares at a price of $2.11 per share.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia, Arthur Marcus, and associate Mayank Pradhan.

Sichenzia Ross Ference Carmel LLP Represents A2Z Smart Technologies Corp. in $3.3 Million Registered Direct Offering and $2.4 Million Private Placement 

Press Release – New York, NY – April 3,  2024 –Sichenzia Ross Ference Carmel LLP announced today that it represented A2Z Smart Technologies Corp. (the “Company”), (NASDAQ: AZ)(TSXV: AZ), a global leader of advanced proved-in-use smart cart solutions, in the Company’s $3.3 million registered direct offering and $2.4 million private placements. 

The Company issued an aggregate of 9,480,500 common shares in the registered direct offering. In addition, the Company has entered into binding agreements with certain investors to issue 6,842,857 common shares in a private placement at a purchase price of $0.35 per share, for gross proceeds of approximately $2.4 million. The private placement is expected to close within 60 days, subject to satisfaction of closing conditions.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia and Avital Perlman, law clerk Rohini Sud and associate Benjamin Sklar. 

Sichenzia Ross Ference Carmel LLP Represents Applied UV, Inc. in a $2.76 Million Registered Direct Offering and Concurrent Private Placement

New York, NY – March 29, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it has represented Applied UV, Inc., (NASDAQ: AUVI; AUVIP) (“Applied UV” or the “Company”) in a $2.76 million registered direct and private placement priced at the market under Nasdaq rules.

The transactions are expected to close on or about April 1, 2024.

As a global leading provider of advanced food security, Applied UV is focused on the development and acquisition of technologies that address infection prevention in the healthcare, hospitality, commercial and municipal markets.

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel, Jeff Wofford, and associate Jeff Hua.

Sichenzia Ross Ference Carmel LLP Represents Verb Technology Company, Inc. in a $9,010,000 At-the-Market (ATM) Offering

Press Release – New York, NY –March 29, 2024 – Sichenzia Ross Ference Carmel LLP represented Verb Technology Company, Inc. (NASDAQ: VERB) (“Verb Technology” or the “Company”), in the offering of $9,010,000 shares of the Company pursuant to an At-The Market Issuance Sales Agreement between Ascendiant Capital Markets, LLC, as sales agent, and the Company, as amended. The shares are being offered and sold pursuant to the Company’s registration statement on Form S-3, including the accompanying base prospectus, and a prospectus supplement, as subsequently supplemented.

Verb Technology is a company focused on interactive video-based sales applications. The Company’s MARKET.live, is a popular livestream social shopping platform. 

The Sichenzia Ross Ference Carmel LLP team was led by partners, Gregory Sichenzia and Marcelle S. Balcombe and by senior paralegal, Raquel Vazquez. 

Sichenzia Ross Ference Carmel LLP Represents Verb Technology Company, Inc. in a $6.6 Million Regulation A Offering of Common Stock of its Common Stock under Regulation A 

Press Release – New York, NY –March 26, 2024 – Sichenzia Ross Ference Carmel LLP represented Verb Technology Company, Inc. (NASDAQ: VERB) (“Verb Technology” or the “Company”), in an offering of shares of its common stock (the “Shares”) for aggregate gross proceeds of approximately $6.6 million. The shares were offered at-the-market under Nasdaq rules and pursuant to the Company’s Form 1-A. The Shares were placed through the efforts of the Company’s Chief Executive Officer, Rory Cutaia. The Company did not pay any commissions in connection with the sale of the Shares.

Verb Technology is a company focused on interactive video-based sales applications. The Company’s MARKET.live, is a popular livestream social shopping platform. 

The Sichenzia Ross Ference Carmel LLP team was led by partners, Marcelle S. Balcombe and Greg Sichenzia and by senior paralegal, Raquel Vazquez.

Sichenzia Ross Ference Carmel LLP Represents EF Hutton in $2 Million Public Offering of AppTech Payments Corp. 

Sichenzia Ross Ference Carmel LLP Represents Beyond Air in $16.0 Million Registered Direct Offering

Press Release – New York, NY – March 22, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Beyond Air, Inc. (NASDAQ: “XAIR”), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions, in a securities purchase agreement whereby the investors have agreed to purchase 9,638,556 shares of the Company’s common stock and warrants to purchase up to an aggregate of 9,638,556 shares of common stock at a purchase price of $1.66 per share and accompanying warrant in a registered direct offering priced at-the-market under Nasdaq rules. 

Roth Capital Partners and Laidlaw & Company (UK) Ltd. acted as co-placement agents for the offering.

The securities in the offering described above are being offered by the Company pursuant to an effective “shelf” registration statement on Form S-3 (File No. 333-262311) previously filed with the U.S. Securities and Exchange Commission (the “SEC”), which was declared effective on February 1, 2022. 

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia and Avital Perlman and associate Soumya Cheedi.

Sichenzia Ross Ference Carmel LLP Represents ShiftPixy, Inc. in $5.0 Million Public Offering

Press Release – New York, NY – March 22, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented ShiftPixy, Inc. (NASDAQ: PIXY), a Florida-based national staffing enterprise, in a $5.0 million public offering. The offering consisted of 590,000 shares of common stock, pre-funded warrants to purchase up to 586,470 shares of common stock, and common warrants to purchase up to 1,176,470 shares of common stock. The offering price was $4.25 per share and accompanying common warrant, or $4.2499 per pre-funded warrant and accompanying common warrant. The company received gross proceeds of approximately $5.0 million, before deducting placement agent’s fees and other offering expenses. A.G.P./Alliance Global Partners acted as placement agent in connection with the offering.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia and Jeff Cahlon and associate Christian Lichtenberger.

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $6 Million Public Offering of C3is Inc.

Press Release – New York, NY – March 20th, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Aegis Capital Corp. as underwriter, in its public offering of C3is Inc. (the “Company” or C3is”).

The now-closed offering consisted of 120,000,000 Units, each containing one share of common stock or Pre-Funded Warrant. The above offering resulted in gross proceeds to the Company of approximately $6.0 million, before deducting underwriting discounts and other estimated expenses payable by the Company. 

C3is is an international shipping transportation company, providing dry bulk and crude oil tanker seaborne services. Their clientele includes major national and private industrial users, commodity producers, and traders.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia, Darrin M. Ocasio, and Jeff Cahlon, and associate Christian Lichtenberger.

Sichenzia Ross Ference Carmel LLP Represents Worksport Ltd. in $2.8 Million Public Offering

Sichenzia Ross Ference Carmel LLP Represents Nature’s Miracle, Inc. in Business Combination with Lakeshore Acquisition II Corp.

Press Release – New York, NY – March 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Nature’s Miracle, Inc. (NASDAQ: NMHI) (“Nature’s Miracle” or the “Company”) as special securities counsel in the successful completion of its previously announced business combination with Lackeshore Acquisition II Corp. The combined public company has been renamed “Nature’s Miracle Holding Inc.” The common stock of the combined company began trading on the Nasdaq Global Market on March 11, 2024, under the ticker symbol “NMHI” and the Company’s warrants began trading on the Nasdaq Capital Market on March 11, 2024, under the ticker symbol “HMHIw”. Nature’s Miracle is a growing Controlled Environment Agriculture (CEA) technology company. 

Partner David Manno commented, “We congratulate Nature’s Miracle on the completion of their business combination and Nasdaq listing.” 

The Sichenzia Ross Ference Carmel LLP team was led by partners Huan Lou and David Manno and associate Mayank Pradhan.

Sichenzia Ross Ference Carmel LLP Represents WallachBeth Capital in a $2.5 Million Public Offering

Press Release – New York, NY – March 11, 2024 – Sichenzia Ross Ference Carmel LLP represented WallachBeth Capital in a registered direct offering and concurrent private placement of bioAffinity Technologies, a company addressing the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer treatments. WallachBeth Capital acted as sole placement agent for the Offering. 

The offering consisted of 1,600,000 shares of common stock in a registered direct offering and common warrants to purchase up to 1,600,000 shares of common stock in a concurrent private placement (together with the registered direct offering) at a combined purchase price of $1.5625 per common share. The common warrants issued pursuant to the concurrent private placement will have an exercise price of $1.64 per share.

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel and Jeffrey Wofford, as well as law clerk Soumya Cheedi

Sichenzia Ross Ference Carmel LLP Represents ThinkEquity LLC and Laidlaw & Company (UK) Ltd. in a $2.1 Million underwritten Public Offering

Press Release – New York, NY –March 1, 2024 – Sichenzia Ross Ference Carmel LLP represented ThinkEquity LLC and Laidlaw & Company (UK) Ltd. in an underwritten public offering of Oragenics Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal nanoparticle pharmaceuticals for the treatment of neurological disorders. The offering consisted of 1,400,000 shares of common stock at $1.50 per share for aggregate gross proceeds of approximately $2,100,000, prior to deducting underwriting discounts and other offering expenses. In addition, the Company granted the underwriters a 45-day option to purchase up to an additional 210,000 shares of common stock. The offering closed on March 1, 2024.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia, Marcelle S. Balcombe, Jeff Cahlon and Senior Paralegal, Raquel Vasquez

Sichenzia Ross Ference Carmel LLP Represents EF Hutton LLC in $1.5 Million Underwritten Public Offering of NRx Pharmaceuticals

Press Release – New York, NY –February 28, 2024 – Sichenzia Ross Ference Carmel LLP represents EF Hutton LLC in $1.5 million underwritten public offering of NRx Pharmaceuticals (the “Company”) (Nasdaq: NRXP), a clinical-stage biopharmaceutical company. The offering consisted of $0.30 per share, for aggregate gross proceeds of approximately $1,500,000, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 750,000 shares of common stock (or pre-funded warrants in lieu thereof). The offering is expected to close on February 28, 2024, subject to satisfaction of customary closing conditions. 

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel, Avital Perlman, and associate Christian Lichtenberger.